Industry specific information to provide guidance on the industry's complex changes, updates and challenges.
Strengthen the Value of Your Products Through Real World Evidence
Learn how Ergomed’s unique set of RWE risk management services are specifically tailored to the needs of your programmes.
Hear a recording of PSR’s webinar “EU Regulatory Innovations Relevant to Orphan Drugs”
This recording is of a webinar that we hosted in April 2018
CEO Today Europe – PSR
We are happy that PSR’s CEO, Roger Legtenberg, was featured in this publication!
Orphan Drug Development Book
This book, available for purchase, was written by our co-founder, Dr Miroslav Reljanović, and is a foremost work on the Orphan Drug market.
Ergomed’s Evolution and Risk-Sharing Business Model In Practice – A Scrip Video Interview
Hear Ergomed’s Chief Business Officer, Andrew Mackie, talk to Scrip about our history and risk-sharing business model.